Antenatal use of enoxaparin for prevention and treatment of thromboembolism in pregnancy

British Journal of Obstetrics and Gynaecology

Volumn 107, Issue 9, 2000, Pages 1116-1121

  Ellison, Joanne ^a   Walker, Isobel D ^a   Greer, Ian A ^a  

^a Glasgow Royal Maternity Hospital and Glasgow Royal Infirmary ^*  (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 10A ANTIBODY; ENOXAPARIN; PROTEIN ANTIBODY; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ARTICLE; BLEEDING; CLINICAL ARTICLE; DRUG EFFICACY; DRUG INDICATION; DRUG SAFETY; FEMALE; HUMAN; INCIDENCE; OSTEOPOROSIS; OUTCOMES RESEARCH; PREGNANCY; PRENATAL PERIOD; PRIORITY JOURNAL; RETROSPECTIVE STUDY; THROMBOCYTOPENIA; THROMBOEMBOLISM; THROMBOPHILIA;

ADOLESCENT; ADULT; ANTICOAGULANTS; ENOXAPARIN; FACTOR XA; FEMALE; GESTATIONAL AGE; HUMANS; PREGNANCY; PREGNANCY COMPLICATIONS, CARDIOVASCULAR; PRENATAL CARE; RETROSPECTIVE STUDIES; THROMBOEMBOLISM; TREATMENT OUTCOME;

EID: 0033812190     PISSN: 03065456     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1471-0528.2000.tb11110.x     Document Type: Article

References (26)

1. Thrombosis in pregnancy: Maternal and fetal issues
2. Thrombosis prophylaxis in obstetrics and gynaecology
3. Venous thromboembolic disease in obstetrics and gynaecology: The Scottish experience
4. Maternal and fetal sequelae of anticoagulation during pregnancy
5. Experimentally induced changes in the prothrombin level of the blood: Prothrombin concentration of new-born pups of a mother given dicoumarol before parturition
6. Danger of dicoumarol treatment during pregnancy
7. No transplacental passage of standard heparin or an enzymatically depolymerized low molecular weight heparin
8. Use of low molecular weight heparin in pregnancy
9. Heparin-induced thrombocytopenia in patients treated with low molecular weight heparin or unfractionated heparin
10. Bone density studies in pregnant women receiving heparin
11. Low molecular weight heparin in prevention of perioperative thrombosis
12. Low molecular weight versus standard heparin in general and orthopaedic surgery: A meta-analysis
13. Heparin
14. Low molecular weight heparin for obstetric thromboprophylaxis: Experience of 69 pregnancies in 61 high risk women
15. Low molecular weight heparin during pregnancy and delivery - Preliminary experience with 41 pregnancies
16. Use of low molecular weight heparin for prophylaxis and treatment of thromboembolism in pregnancy
17. Thromboprophylaxis with low molecular weight heparin (Fragmin) in high risk pregnancies
18. Low molecular weight heparin for thromboprophylaxis and epidural/spinal anaesthesia: Is there a risk?
19. Heparin-induced thrombocytopenia in patients treated with low molecular weight heparin or unfractionated heparin
20. Thrombocytopenia associated with low molecular weight heparin
21. Heparin-associated thrombocytopenia caused by low molecular weight heparin
22. Pregnancy complications in women with recurrent miscarriage associated with antiphospholipid antibodies treated with low dose aspirin and heparin
23. Bone mineral density during long-term prophylaxis with heparin in pregnancy
24. Heparin-induced skin reaction due to two different preparations of low molecular weight heparin (LMWH)
25. Delayed-type allergy for heparin and fractions of low-molecular-weight heparin